Project Grant R01MH141437
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Texas at Austin a $3.09 million Mental Health Research Grants (CFDA 93.242) project grant for the period July 1, 2026 through June 30, 2030. The research project investigates synaptic plasticity mechanisms that protect and refine local neural circuits, with particular focus on understanding how dendritic spine structure supports learning and memory. The primary deliverables include...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Texas Rio Grande Valley $536,418 under the Mental Health Research Grants program (CFDA 93.242) to enhance PALM (Permutation Analysis of Linear Models), a free and open-source statistical analysis tool used in brain imaging research. The three-year project, awarded September 1, 2025, and extending through August 31, 2028, will develop and implement advanced statistical methods to address the...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The University of Texas Southwestern Medical Center a Project Grant totaling $1,157,832 under the Mental Health Research Grants program (CFDA 93.242), effective August 26, 2025, with completion scheduled for May 31, 2030. The grant supports a five-year research initiative investigating the regulation and function of DNA methyltransferase 3A (DNMT3A)-mediated methylation in the brain, with particular focus on...
- Federal Grant Award Summary Rockefeller University received a $768,000 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded September 20, 2025, with completion targeted for June 30, 2030. The award funds development of next-generation optical imaging technology and genetically encoded voltage indicators (GEVIs) to enable high-fidelity population voltage imaging in neural tissue. The primary deliverable is an...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Wisconsin–Madison a Project Grant totaling $150,900 under the Mental Health Research Grants program (CFDA 93.242) on September 17, 2025, with a completion date of March 31, 2027. This award funds basic neuroscience research investigating the mechanisms underlying the development, evolution, and function of human-specific cortical dopaminergic interneurons. The research addresses a critical gap in...
- Federal Grant Award Summary The University of Michigan received a $3,977,894 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded August 1, 2025, with completion targeted for July 31, 2028. This grant funds development of a scalable high-plex pipeline for whole-brain proteomics profiling that addresses critical gaps in molecular characterization of distinct brain cell types. The project delivers a comprehensive...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Texas Health Science Center at Houston $1,125,194 under the Mental Health Research Grants program (CFDA 93.242) effective August 15, 2025, through August 14, 2027. This Project Grant funds a clinical research trial investigating the efficacy of bilateral repetitive transcranial magnetic stimulation (rTMS) targeting the prefrontal and insular cortices for treating comorbid depression in patients...
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded $837,097 to The University of Texas Southwestern Medical Center on September 22, 2025, under the Mental Health Research Grants program (CFDA 93.242) to conduct a five-year imaging study examining microglia proliferation and its relationship to cognitive control deficits in virally-suppressed people with human immunodeficiency virus (VS+PWH). The project, extending through May 31, 2030, utilizes positron...
- Federal Project Grant Award Summary The University of Texas at Arlington received a $769,753 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded July 21, 2025, with completion targeted for April 30, 2030. This research initiative aims to identify neural biomarkers and biotypes underlying posttraumatic stress disorder (PTSD), major depressive disorder (MDD), and anxiety disorders (ANXs) by leveraging...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Massachusetts Institute of Technology a $803,849 Project Grant effective June 3, 2026, through March 31, 2031, under the Mental Health Research Grants program (CFDA 93.242). This research initiative will deliver advanced neuroscience research services focused on understanding reward system function in the brain through innovative functional magnetic resonance imaging (fMRI) techniques. The project will utilize a...
The University of Texas at Austin received a $629,098 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), effective June 1, 2026 through February 28, 2031. The award supports the development and characterization of advanced optical and sono-chemogenetic systems for probing dopamine dynamics in the non-human primate brain, specifically utilizing the macaque animal model. The project delivers two primary technical products: (1) establishment and characterization of the dLight sensor, a genetically encoded fluorescent dopamine indicator for real-time visualization of dopamine activity in primate neural circuits, and (2) development of an innovative sono-chemogenetic approach that leverages ultrasound-programmable nanoparticles for non-invasive, spatially-targeted modulation of dopamine signaling. These tools address a critical methodological gap by extending cell-type-specific neural recording and manipulation capabilities from smaller animal models to larger primates, which serve as essential preclinical models for advancing understanding of dopamine-related neurological and neuropsychiatric conditions. The deliverables generated through this research funding include validated methodologies, experimental datasets, and characterization protocols applicable to dopamine circuitry research in primate systems. These products support the broader NIMH mission of transforming understanding and treatment of mental illnesses through basic and clinical research by providing researchers with sophisticated new technologies for investigating dopamine's role in cognitive processes and disease states. The work facilitates advancement of neurotherapeutic development and establishes foundational tools for future translational research in primate neuroscience models.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $629.1k | 6/5/26 |